In patients with a positive family history of familial adenomatous polyposis can the condition be diagnosed from the presence of congenital hypertrophy of the retinal pigment epithelium detected via an eye examination: A systematic review.
Shahzaib RehanKyaw AyePublished in: Clinical & experimental ophthalmology (2019)
In classic familial adenomatous polyposis (FAP) adenomas become malignant. Congenital hypertrophy of the retinal pigment epithelium (CHRPE) is a retinal pigmented lesion and is the earliest and most common potential extraintestinal manifestation of FAP. This review aims to summarize and analyse all of the published data on CHRPE in patients with classic FAP and then ascertain whether these patients should undergo a relatively cheap and non-invasive dilated fundus examination to screen for CHRPE. Adhering to Preferred Reporting Items for Systematic Reviews and Meta Analyses guidelines our database search identified 102 relevant articles of which 13 were selected for further analysis. The percentage of FAP patients with CHRPE was found to be 80.00%, whereas the percentage of at-risk patients with CHRPE was 31.12%. Despite various statistically significant findings, CHRPE alone cannot be used as a surrogate for diagnosing FAP in those with a positive family history. The authors advocate a combined approach of eye examinations, colonoscopy and genetic testing.
Keyphrases
- meta analyses
- systematic review
- end stage renal disease
- diabetic retinopathy
- ejection fraction
- newly diagnosed
- randomized controlled trial
- early onset
- chronic kidney disease
- prognostic factors
- optical coherence tomography
- peritoneal dialysis
- high throughput
- patient reported outcomes
- chronic rhinosinusitis
- risk assessment
- deep learning
- human health